Mark Gumbleton
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Neurology top 2%
- Barrier Structure and Function Studies
Papers in
-
- RNA Interference and Gene Delivery 9
- Ion Transport and Channel Regulation 8
-
- Inhalation and Respiratory Drug Delivery 14
- Co-authors
- Lee Ann Campbell (22 shared papers)Mathew W. Smith (11 shared papers)Kenneth L. Audus (1 shared paper)Muthanna Abdulkarim (14 shared papers)Yadollah Omidi (7 shared papers)Carsten Ehrhardt (6 shared papers)Abedelnasser Abulrob (5 shared papers)Andrew J. Hollins (6 shared papers)
- Journals
- Advanced Drug Delivery Reviews (10 papers)Pharmaceutical Research (8 papers)International Journal of Pharmaceutics (8 papers)Journal of Controlled Release (6 papers)Journal of Pharmaceutical Sciences (5 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Mark Gumbleton
120 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 138
- Pharmaceutical Science 769
- Neurology 322
- Pulmonary and Respiratory Medicine 879
- Biomaterials 370
- Oncology 670
Countries citing papers authored by Mark Gumbleton
This map shows the geographic impact of Mark Gumbleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gumbleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gumbleton more than expected).
Fields of papers citing papers by Mark Gumbleton
This network shows the impact of papers produced by Mark Gumbleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gumbleton. The network helps show where Mark Gumbleton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Gumbleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 221 | |
| 2 | 2003 | 210 | |
| 3 | 2010 | 196 | |
| 4 | 2006 | 136 | |
| 5 | 2003 | 128 | |
| 6 | 2015 | 125 | |
| 7 | 2018 | 108 | |
| 8 | 1999 | 104 | |
| 9 | 2015 | 102 | |
| 10 | 1999 | 100 | |
| 11 | 2010 | 94 | |
| 12 | 2003 | 88 | |
| 13 | 2001 | 84 | |
| 14 | 2003 | 80 | |
| 15 | 2019 | 80 | |
| 16 | 2012 | 78 | |
| 17 | 2009 | 76 | |
| 18 | 2000 | 76 | |
| 19 | 2009 | 71 | |
| 20 | 2018 | 70 |
About Mark Gumbleton
Mark Gumbleton is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cell Biology, Oncology and Pharmaceutical Science, having authored 121 papers that have together received 4.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (20 papers), Caveolin-1 and cellular processes (20 papers), Inhalation and Respiratory Drug Delivery (14 papers), Advanced Drug Delivery Systems (12 papers), RNA Interference and Gene Delivery (9 papers), Ion Transport and Channel Regulation (8 papers), Erythrocyte Function and Pathophysiology (7 papers) and Drug Solubulity and Delivery Systems (6 papers). The work is most often cited by research in Pharmaceutical Science (769 citations), Neurology (322 citations), Pulmonary and Respiratory Medicine (879 citations), Biomaterials (370 citations) and Oncology (670 citations). Mark Gumbleton has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Lee Ann Campbell, Mathew W. Smith, Kenneth L. Audus, Muthanna Abdulkarim, Yadollah Omidi, Carsten Ehrhardt, Abedelnasser Abulrob, Andrew J. Hollins, Andreas Bernkop‐Schnürch and Jaleh Barar. Their work appears in journals such as Advanced Drug Delivery Reviews, Pharmaceutical Research, International Journal of Pharmaceutics, Journal of Controlled Release and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.